creativebiolabs2018
As a global company, we have more than 200 talented and well-trained scientists located in different continents working closely with partners from the entire world to develop and produce medicines of tomorrow.
Creative Biolabs has over a decade of working experience in antibody design and modification to fit various bio-conjugation strategies. Learn more about conjugation of dar.
Creative Biolabs offers customized services for the design and production of antibody-drug conjugates (ADCs) using auristatin and auristatin derivatives as payloads. Learn more from mmaf.
Monoclonal antibody-based immunotherapies against cancer and other infectious diseases are highly advantageous comparing to conventional therapeutic approaches due to their high specificity and affinity towards well-defined targets. Learn more about adc delivery.
The work here at Creative Biolabs to create antibody-drug conjugates (ADCs) are empowered by our advanced technical platforms. Learn more about adc technologies.
Creative Biolabs provides the most comprehensive cysteine-based conjugation approaches to generate highly customized ADCs in a timely and cost efficient way. Learn more about cysteine maleimide.
Creative Biolabs offers customized services for the design and production of antibody-drug conjugates (ADCs) using auristatin and auristatin derivatives as payloads. Learn more about mmae.
Monoclonal antibody-based immunotherapies against cancer and other infectious diseases are highly advantageous comparing to conventional therapeutic approaches due to their high specificity and affinity towards well-defined targets. Learn more about antibody-drug conjugates.
Creative Biolabs has over a decade of working experience in antibody design and modification to fit various bio-conjugation strategies, especially for the development of antibody-drug conjugates (ADCs). Learn more about antibody conjugates.
The carbohydrate moiety on an antibody is located at the hinge region of the Fc domain, with a sufficient distant from the variable region that regulates antigen interaction. Learn more about maleimide conjugation.
With a comprehensive understanding and extensive experience in antibody-drug conjugate (ADC) developments, Creative Biolabs offers highly customized ADC design and preparation using amatoxin and amatoxin analogs as payloads. Learn more about amatoxin.
With our advanced “DrugLnk” platform and extensive experience in synthetic chemistry and bio-conjugation, Creative Biolabs offers highly customized strategies for antibody-drug conjugates (ADCs) production and targeted antibody therapy development using doxorubicin or doxorubicin derivatives as payloads. Learn more about doxorubicin moa.
Creative Biolabs is a leader in antibody engineering, modification, and production. With years of accumulative work, we have established an advanced “DrugLnk” platform to provide highly customized strategies. Learn more about ipatasertib.
Erb-b2 receptor tyrosine kinase 2(ERBB2), commonly referred to as HER2, is an epidermal growth factor (EGF) receptor family tyrosine kinase. It is also referred to as ERBB2, NEU, NGL, TKR1, CD340, MLN 19, or HER-2/neu under different circumstances and it is a unique EGF receptor. Learn more about her2 adc.
Creative Biolabs has established a comprehensive service program for antibody-drug conjugates (ADCs) developments. Learn more about maytansinoid.
Creative Biolabs offers a large collection of pre-assembled drug-linker complexes for ready-to-go antibody conjugation to speed up new antibody-drug conjugate (ADC) development processes. Learn more about mc vc pab mmae.
Creative Biolabs provides services to prepare various taxoids containing antibody-drug conjugates (ADCs) with high potency and tumor specificity.
Creative Biolabs offers epothilones conjugated ADCs with the most suitable linkers and optimized conjugation strategies to serve clients’ specific requirements. Learn more about epothilones.
Creative Biolabs provides various formats of quantification assays to determine the in vivo pharmacokinetics profiles of an ADC. Learn more about adc characterization.
Creative Biolabs offers customarily prepared high quality antibody-drug conjugates (ADCs). Learn more about duocarmycin adc.
Creative Biolabs has established an advanced “DrugLnk” organic synthesis platform to promote the design and preparation of various drug-linker complexes. Learn more about ph sensitive linker.
Creative Biolabs is a pioneer in antibody-drug conjugate (ADC) development and our science team provides customized ADCs with tubulysins as payload drugs.
Tubulysins, originally isolated from myxobacteria, are a series of antimitotic tetrapeptides discovered by Hofle and co-workers in 2000. Learn more about tubulin filaments.
Creative Biolabs offers a variety of chemically versatile linker molecules to facilitate antibody-drug conjugate (ADC) development projects.Learn more about val cit pab.
Creative Biolabs provides highly customized services for the preparation of ADCs and other targeted antibody therapeutics using methotrexate (MTX) and its analogues as payloads.Learn more about dhfr methotrexate.
Creative Biolabs offers customarily prepared high quality antibody-drug conjugates (ADCs) using duocarmycin and duocarmycin analogs as payloads for targeted anti-cancer therapies and a variety of other applications.
